早期HPV阳性口咽癌经口机器人手术后游离皮瓣重建的功能结局
本研究回顾性分析2010至2022年单中心接受经口机器人手术(TORS)的早期HPV阳性口咽鳞癌患者,比较游离皮瓣重建(FFR)与未重建(nFFR)的功能结局。经1:2倾向性评分匹配后纳入93例,FFR组再手术率(19% vs 3.3%,P<.001)和平均住院日(7.2±2.2 vs 4.9±3.1天,P=.02)更高,但1年后吞咽功能(FOIS)两组相似(6.00 vs 6.00,P=.3)。作者认为FFR是pT1-2肿瘤经TORS切除后可行的重建选择。
要点
- FFR组再手术率19% vs nFFR组3.3%(P<.001),平均住院日7.2±2.2 vs 4.9±3.1天(P=.02)。
- 术后3和6个月nFFR组FOIS更高(5.00 vs 6.00,P=.04),1年后两组相似(6.00 vs 6.00,P=.3)。
- 作者认为FFR是pT1-2肿瘤经TORS切除后可行的重建选择。
核心结论
- FFR在1年时达到与nFFR相当的功能结局。
- 作者认为FFR是pT1-2肿瘤经TORS切除后可行的重建选择,即使存在咽后颈动脉等解剖屏障。
研究设计与样本
- 回顾性电子病历综述,纳入2010年至2022年单中心三级医疗中心接受TORS的早期HPV阳性口咽鳞癌患者。
- 队列分为FFR组(伴咽后颈动脉)和nFFR组,进行1:2倾向性评分匹配(PSM)。
- 匹配后93例患者纳入分析,平均年龄59.8岁,92%白人,88%男性;31例(33%)接受FFR,77例(83%)为pT2肿瘤,87例(93%)接受辅助治疗。
主要发现
- FFR组再手术率高于nFFR组(19% vs 3.3%,P<.001)。
- FFR组平均住院日长于nFFR组(7.2±2.2 vs 4.9±3.1天,P=.02)。
- 术前FOIS中位数两组相似(FFR:7.00[IQR 6.00-7.00] vs nFFR:7.0[7.00-7.00],P=.2),首次随访时下降程度相当。
- 术后3和6个月nFFR组FOIS高于FFR组(5.00[5.00-6.00] vs 6.00[5.00-7.00],P=.04)。
- 1年后FOIS两组相似(6.00[5.00-7.00] vs 6.00[6.00-7.00],P=.3)。
临床怎么用
- 作者认为FFR是pT1-2肿瘤经TORS切除后可行的重建选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the unique clinical context of a retropharyngeal carotid artery (RPC), free flap reconstruction (FFR) may be used for small pathologic tumor (pT)1-2 human papillomavirus (HPV)+ oropharyngeal squamous cell carcinoma (OPSCC) tumors to provide vessel coverage, providing a unique case-control study model. This study aims to elucidate the impact of FFR on functional outcomes following transoral robotic surgery (TORS). STUDY DESIGN: Retrospective review of electronic medical records between 2010 and 2022. SETTING: Single-institution tertiary care center. METHODS: Cohorts were defined as FFR (with RPC) and no FFR (nFFR). A 1:2 propensity score match (PSM) was performed. The functional oral intake scale (FOIS) was used to characterize swallowing outcomes. Statistical analysis was performed in R-Studio. RESULTS: Post-PSM, 93 patients met inclusion criteria (59.8 years, 92% white, 88% male). In total, 31 (33%) underwent FFR, 77 (83%) had pT2 tumors, and 87 (93%) underwent adjuvant treatment. The FFR cohort saw increased return to the operating room (FFR 19% vs nFFR 3.3%, P < .001) and mean hospital stay (7.2 ± 2.2 vs 4.9 ± 3.1 days, P = .02). Median preoperative FOIS was similar between groups (FFR: 7.00 [interquartile range (IQR) 6.00-7.00] vs nFFR: 7.0 [7.00-7.00], P = .2) with comparable decline at first follow-up. The nFFR cohort had higher FOIS at 3 and 6 months (5.00 [5.00-6.00] vs 6.00 [5.00-7.00], P = .04). FOIS was similar after 1 year (6.00 [5.00-7.00] vs 6.00 [6.00-7.00], P = .3). CONCLUSION: FFR achieved comparable functional outcomes to nFFR at 1 year. FFR is a viable reconstructive option for pT1-2 tumors for which TORS that are amenable to surgical resection via TORS despite an anatomic barrier such as RPC.
引用
- Kaki PC, Sangal NR, Lam D, et al. Functional Outcomes of Free Flap Reconstruction After TORS in Early-Stage HPV-Positive Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2025. PMID: 40067015. doi:10.1002/ohn.1221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。